CN104587077A - Traditional Chinese medicine composition for treating vitiligo antigens - Google Patents
Traditional Chinese medicine composition for treating vitiligo antigens Download PDFInfo
- Publication number
- CN104587077A CN104587077A CN201510043979.5A CN201510043979A CN104587077A CN 104587077 A CN104587077 A CN 104587077A CN 201510043979 A CN201510043979 A CN 201510043979A CN 104587077 A CN104587077 A CN 104587077A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- traditional chinese
- antigens
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating vitiligo antigens. The traditional Chinese medicine composition is prepared from the following raw materials: fructus psoraleae, red peony root, davallia mariesii, salviae miltiorrhizae, mylabris, flos carthami, semen cuscutae, polygonum multiflorum, lamiophlomis rotata, dried radix rehmanniae, cassia twig, fructus cnidii, viola philippica, decumbent corydalis tuber, cortex lycii radicis, cistanche salsa, mistletoe, aleppo avens, cortex mori radicis and morinda officinalis. According to the traditional Chinese medicine composition disclosed by the invention, conventional auxiliary materials are added to prepare clinically acceptable ointment, spray, liniment, tincture, capsule, tablet, pill, granule, decoction or oral liquid according to the conventional processes. The traditional Chinese medicine composition disclosed by the invention has the functions of warming the liver and kidneys, dispelling wind, removing dampness, harmonizing qi and blood, clearing and activating the channels and collaterals, promoting blood circulation to remove blood stasis, and regulating the immunity, and improving the skin microcirculation, and has the characteristics of being accurate in curative effect, high in recovery rate, safe, convenient and free of a toxic or side effect on treatment and prevention of vitiligo antigens.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to one and treat leukodermic Chinese medicine composition.
Background technology
(another name: leucoderma, vitiligo are English: leucoderma) be that a kind of common posteriority limit office property or general property skin pigment depigmentation are sick, mainly the melanocyte function disappearance of skin causes vitiligo.All may fall ill in each position of vitiligo whole body, commonly the back of the body, wrist, forearm, face, neck and surrounding genital etc.The pathogenic factor that vitiligo is concrete it be unclear that, research think with theory of heredity, spirit relevant with the factor such as neuro chemistry theory, melanocyte autoclasia theory.Vitiligo asexuality, age differences.
Summary of the invention
The object of the invention is to provide one to treat leukodermic Chinese medicine composition.
The present invention is achieved through the following technical solutions:
The crude drug of Chinese medicine composition of the present invention consists of:
The crude drug composition of Chinese medicine composition of the present invention is preferably:
The crude drug composition of Chinese medicine composition of the present invention is preferably:
The crude drug composition of Chinese medicine composition of the present invention is preferably:
Pharmaceutical composition of the present invention conveniently technique adds customary adjuvant and makes the ointment of clinical acceptance, spray, liniment, tincture, capsule, tablet, pill, granule, decoction or oral liquid.
Chinese medicine composition of the present invention has the functions such as temperature compensation Liver and kidney, expelling wind and removing dampness, QI and blood regulating, dredge the meridian passage, blood circulation promoting and blood stasis dispelling, immunity moderation, effect of skin microcirculation can also be improved, have that determined curative effect, cure rate are high to treatment and prevention vitiligo, safe ready, the feature that has no side effect.
Experimental example is used for further illustrating the present invention below, but is not limited to the present invention.
Experimental example one: clinical trial
1, clinical observation
Liniment of the present invention (according to the preparation of embodiment 1 method) is to treatment patients with vitiligo 100 example, wherein male 50 example, and women 50 is routine.
2, medicament selection
Treatment group anthology invention liniment (according to the preparation of embodiment 1 method), treat 3 courses for the treatment of (10 days each courses for the treatment of), a twice-daily is wiped in affected part.
3, diagnostic criteria
1) the morbidity day after tomorrow, agnogenic depigmentation speckle.White macula is often creamy white, and size, form differ, and on it, hair can normally or bleach.
2) homeliness type (topical type, general hair style, distribute type, acra type) and segmental pattern is divided into according to the feature of erythra distribution.Homeliness type skin lesion is generally symmetrical, some position can be confined to or distribute, general whole body. segmental pattern is generally one-sided, and white macula is along a certain tegumentary nerve joint domination district's distribution.Whether be divided into for two phases: progressive stage and stable phase according to state of an illness activity.Progressive stage is that former white macula is still expanding, obscurity boundary, and can have a new skin lesion, can have isomorphic response; Stable phase is that former white macula stops development, and sends out skin lesion, without isomorphic response without new.
3) course of disease is slow, without obvious subjective symptoms.
4) hypopigmentation that other reason causes or the white macula that depigmentation causes can be got rid of.
4, criterion of therapeutical effect
" in cure the desease Standardization of diagnosis and curative effect " of implementing with reference to State Administration of Traditional Chinese Medicine 1994 drafts as follows:
Clinical recovery: tcm clinical practice symptom, sign disappear or substantially disappear;
Effective: tcm clinical practice symptom, sign obviously change;
Effective: tcm clinical practice symptom, sign all take a favorable turn;
Invalid: tcm clinical practice symptom, sign are all not improved;
5, therapeutic outcome
| Group | Treatment number | Cure | Effective | Effectively | Invalid | Total effective rate |
| Treatment group | 100 | 85 | 14 | 1 | 0 | 100％ |
6, conclusion
100 routine patients use 3 courses for the treatment of of liniment of the present invention, and therapeutic outcome shows, and total effective rate is 100%.
Experimental example two: model case
Case 1: Wang, man, 14 one full year of life, main suit: right face occurred unknown cause white macula, history of present illness before two months: right face white macula, without history of past illness and Genetic history, diagnosis: show the white macula that right face is not of uniform size under wood's lamp, obscure boundary Chu, is diagnosed as vitiligo.Treatment: uses liniment of the present invention (according to the preparation of embodiment 1 method) two course for the treatment of (10 days each courses for the treatment of, every day twice) rear face white maculas substantially to disappear, continues to strengthen treatment one the rear face white macula course for the treatment of and all disappears, healing.With the recurrence of note nothing after 1 year.
Case 2: Zhang, female, 44 one full year of life, main suit: before 30 years, cervical region, lower jaw, chest find white macula, history of present illness: the white macula that cervical region, lower jaw, chest are not of uniform size, without history of past illness and Genetic history, diagnosis: stable phase vitiligo; Treatment: uses spray of the present invention (preparing according to embodiment 2 method) two course for the treatment of (10 days each courses for the treatment of, every day twice) melanin generation is good afterwards, white macula disappears substantially, and after continuing to strengthen a course for the treatment of of treatment, white macula all disappears, and cures.With the recurrence of note nothing after 1 year.
Case 3: river so-and-so, man, 28 one full year of life, main suit: forehead, face position white macula 3 years, history of present illness: forehead, face position white macula, without history of past illness and Genetic history, diagnosis: vitiligo, treatment: take capsule of the present invention (according to the preparation of embodiment 3 method) two course for the treatment of (10 days each courses for the treatment of, daily twice, each 2), forehead and white patch on the face disappear substantially, and continue to take a course for the treatment of of capsule of the present invention, forehead and white patch on the face all disappear, cure, with the recurrence of note nothing after 1 year.
Following embodiment all can realize the effect of above-mentioned experimental example.
Detailed description of the invention
Embodiment 1 liniment
Said medicine conveniently technique adds customary adjuvant and makes liniment, every twice-daily.
Embodiment 2 spray
Said medicine conveniently technique adds customary adjuvant and makes spray.Every twice-daily.
Embodiment 3 capsule
Said medicine conveniently technique adds customary adjuvant and makes capsule.Every twice-daily.
Embodiment 4 tablet
Said medicine conveniently technique adds customary adjuvant and makes tablet.
Embodiment 5 granule
Said medicine conveniently technique adds customary adjuvant and makes granule.
Embodiment 6 ointment
Said medicine conveniently technique adds customary adjuvant and makes ointment.
Claims (6)
1. treat a leukodermic Chinese medicine composition, it is characterized in that, the crude drug of said composition consists of:
2. Chinese medicine composition as claimed in claim 1, is characterized in that the crude drug of said composition consists of:
3. Chinese medicine composition as claimed in claim 1, is characterized in that the crude drug of said composition consists of:
4. pharmaceutical composition as claimed in claim 1, is characterized in that the crude drug of said composition consists of:
5. the Chinese medicine composition as described in one of claim 1-4, it is characterized in that said composition conveniently technique add customary adjuvant and make the ointment of clinical acceptance, spray, liniment, tincture, capsule, tablet, pill, granule, decoction or oral liquid.
6. the application of the Chinese medicine composition as described in one of claim 1-4 in the leukodermic medicine of preparation treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510043979.5A CN104587077A (en) | 2015-01-29 | 2015-01-29 | Traditional Chinese medicine composition for treating vitiligo antigens |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510043979.5A CN104587077A (en) | 2015-01-29 | 2015-01-29 | Traditional Chinese medicine composition for treating vitiligo antigens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104587077A true CN104587077A (en) | 2015-05-06 |
Family
ID=53113348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510043979.5A Pending CN104587077A (en) | 2015-01-29 | 2015-01-29 | Traditional Chinese medicine composition for treating vitiligo antigens |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104587077A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108714167A (en) * | 2018-08-13 | 2018-10-30 | 广西国际壮医医院 | A kind of traditional Chinese medicine for external application and preparation method thereof for treating leucoderma |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1475243A (en) * | 2002-08-12 | 2004-02-18 | 周秀英 | External medicine for treating leucoderma |
| CN101041041A (en) * | 2007-04-20 | 2007-09-26 | 于振鹏 | Chinese traditional medicine compound took orally for treating vitligo |
| CN101496844A (en) * | 2009-03-19 | 2009-08-05 | 董娜 | External preparation for treating leukoderma and method for preparing and using the same |
| CN102366527A (en) * | 2011-09-04 | 2012-03-07 | 成都绿迪科技有限公司 | Traditional Chinese medicine formula for treating vitiligo |
-
2015
- 2015-01-29 CN CN201510043979.5A patent/CN104587077A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1475243A (en) * | 2002-08-12 | 2004-02-18 | 周秀英 | External medicine for treating leucoderma |
| CN101041041A (en) * | 2007-04-20 | 2007-09-26 | 于振鹏 | Chinese traditional medicine compound took orally for treating vitligo |
| CN101496844A (en) * | 2009-03-19 | 2009-08-05 | 董娜 | External preparation for treating leukoderma and method for preparing and using the same |
| CN102366527A (en) * | 2011-09-04 | 2012-03-07 | 成都绿迪科技有限公司 | Traditional Chinese medicine formula for treating vitiligo |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108714167A (en) * | 2018-08-13 | 2018-10-30 | 广西国际壮医医院 | A kind of traditional Chinese medicine for external application and preparation method thereof for treating leucoderma |
| CN108714167B (en) * | 2018-08-13 | 2021-05-07 | 广西国际壮医医院 | A Chinese medicinal preparation for external use for treating vitiligo, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN104161868A (en) | Drug for treating rheumatoid arthritis | |
| CN104147462A (en) | Medicine for treating psoriasis vulgaris | |
| CN104027461A (en) | Traditional Chinese medicine composition for treating urticaria | |
| CN103356925B (en) | Traditional Chinese medicine composition for treating sperm non-liquified symptom | |
| CN102526632B (en) | Traditional Chinese medicine for curing allergic dermatitis | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN102600351B (en) | Traditional Chinese medicine for treating pruritus cutanea | |
| CN102258599B (en) | Chinese medicine for treating cardiovascular diseases | |
| CN104587077A (en) | Traditional Chinese medicine composition for treating vitiligo antigens | |
| CN103055055A (en) | Traditional Chinese medicine for treating skin diseases | |
| CN105194227A (en) | Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills | |
| CN105749216A (en) | Traditional Chinese medicine wine for treating hypertension and preparation method thereof | |
| CN104248677A (en) | Traditional Chinese medicinal preparation for treating erythema multiforme | |
| CN104645207A (en) | Traditional Chinese medicine composition for treating angina | |
| CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
| CN104740075A (en) | Traditional Chinese medicine for treating periomethritis | |
| CN102824471B (en) | Traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain | |
| CN102836403B (en) | Chinese medicine for treating chronic nephritis by using root of low greenbrier | |
| CN102389549B (en) | Traditional Chinese medicinal composition for treating psoriasis | |
| CN102940814B (en) | Medicine for treating tubal nowhere | |
| CN102743580B (en) | Traditional Chinese medicine pill for treating vitligo | |
| CN105687665A (en) | Traditional Chinese medicine composition for treating acne | |
| CN104940712A (en) | Traditional Chinese medicine preparation for treating arteriosclerosis | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150506 |
|
| RJ01 | Rejection of invention patent application after publication |